Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis
Clinical trial NCT06631170 · COMPLETED
Trial details
- NCT number
- NCT06631170
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2025-05-27
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.